| Mr Gavin Blair Gore, | |
|
19500 Sandridge Way, Suite 420, Leesburg, VA 20176-3467 | |
| (571) 375-8601 | |
| (571) 223-6773 |
| Full Name | Mr Gavin Blair Gore |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 19500 Sandridge Way, Suite 420, Leesburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316189608 | NPI | - | NPPES |
| 1316189608 | Medicaid | VA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reston Hospital Center | Reston, VA | Hospital |
| Lewisgale Medical Center | Salem, VA | Hospital |
| Stonesprings Hospital Center | Dulles, VA | Hospital |
| Lewisgale Hospital Montgomery | Blacksburg, VA | Hospital |
| Lewisgale Hospital Alleghany | Low moor, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reston Radiology Consultants, Pc | 1557436730 | 21 |
| Radiology Associates Of Roanoke, Pc | 2365407574 | 9 |
| Reston Radiology Consultants, Pc | 1557436730 | 21 |
| Mri Of Reston Limited Partnership | 3476544701 | 10 |
| Pet Of Reston, Lp | 7214975978 | 5 |
News Archive
Consumption of a type of starch that acts like fiber may help reduce colorectal cancer risk associated with a high red meat diet, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Research suggests that limiting the length of shifts may not cut medical error rates, but restricting hours for doctors in training may offer other reasons for concern.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
A new analysis has found that a considerable proportion of patients with end-stage or terminal cancer do not benefit from palliative radiation therapy despite spending most of their remaining life undergoing treatments. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that greater efforts are needed to tailor appropriately palliative radiotherapy to patients with end-stage cancer.
› Verified 8 days ago
| Entity Name | Loudoun Medical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679591440 PECOS PAC ID: 0042119661 Enrollment ID: O20041115000474 |
News Archive
Consumption of a type of starch that acts like fiber may help reduce colorectal cancer risk associated with a high red meat diet, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Research suggests that limiting the length of shifts may not cut medical error rates, but restricting hours for doctors in training may offer other reasons for concern.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
A new analysis has found that a considerable proportion of patients with end-stage or terminal cancer do not benefit from palliative radiation therapy despite spending most of their remaining life undergoing treatments. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that greater efforts are needed to tailor appropriately palliative radiotherapy to patients with end-stage cancer.
› Verified 8 days ago
| Entity Name | Radiology Associates Of Roanoke, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962442293 PECOS PAC ID: 2365407574 Enrollment ID: O20041130000584 |
News Archive
Consumption of a type of starch that acts like fiber may help reduce colorectal cancer risk associated with a high red meat diet, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Research suggests that limiting the length of shifts may not cut medical error rates, but restricting hours for doctors in training may offer other reasons for concern.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
A new analysis has found that a considerable proportion of patients with end-stage or terminal cancer do not benefit from palliative radiation therapy despite spending most of their remaining life undergoing treatments. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that greater efforts are needed to tailor appropriately palliative radiotherapy to patients with end-stage cancer.
› Verified 8 days ago
| Entity Name | Loudoun Imaging Center / Ashburn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568615094 PECOS PAC ID: 0042371429 Enrollment ID: O20081203000633 |
News Archive
Consumption of a type of starch that acts like fiber may help reduce colorectal cancer risk associated with a high red meat diet, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Research suggests that limiting the length of shifts may not cut medical error rates, but restricting hours for doctors in training may offer other reasons for concern.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
A new analysis has found that a considerable proportion of patients with end-stage or terminal cancer do not benefit from palliative radiation therapy despite spending most of their remaining life undergoing treatments. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that greater efforts are needed to tailor appropriately palliative radiotherapy to patients with end-stage cancer.
› Verified 8 days ago
| Entity Name | Reston Radiology Consultants, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235307034 PECOS PAC ID: 1557436730 Enrollment ID: O20160527000029 |
News Archive
Consumption of a type of starch that acts like fiber may help reduce colorectal cancer risk associated with a high red meat diet, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Research suggests that limiting the length of shifts may not cut medical error rates, but restricting hours for doctors in training may offer other reasons for concern.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
A new analysis has found that a considerable proportion of patients with end-stage or terminal cancer do not benefit from palliative radiation therapy despite spending most of their remaining life undergoing treatments. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that greater efforts are needed to tailor appropriately palliative radiotherapy to patients with end-stage cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Gavin Blair Gore, 224-d Cornwall Street, Nw, Suite 403, Leesburg, VA 20176-2704 Ph: (703) 737-6010 | Mr Gavin Blair Gore, 19500 Sandridge Way, Suite 420, Leesburg, VA 20176-3467 Ph: (571) 375-8601 |
News Archive
Consumption of a type of starch that acts like fiber may help reduce colorectal cancer risk associated with a high red meat diet, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Research suggests that limiting the length of shifts may not cut medical error rates, but restricting hours for doctors in training may offer other reasons for concern.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
A new analysis has found that a considerable proportion of patients with end-stage or terminal cancer do not benefit from palliative radiation therapy despite spending most of their remaining life undergoing treatments. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that greater efforts are needed to tailor appropriately palliative radiotherapy to patients with end-stage cancer.
› Verified 8 days ago
Dr. Scott E Cassar, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 19500 Sandridge Way, Suite 420, Leesburg, VA 20176 Phone: 571-375-8601 Fax: 571-223-6773 | |
Karan Lotfi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 19500 Sandridge Way, Suite 420, Leesburg, VA 20176 Phone: 571-375-8601 Fax: 571-223-6773 | |
Duyanh T Vu, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 19500 Sandridge Way, Suite 420, Leesburg, VA 20176 Phone: 571-375-8601 Fax: 571-223-6773 | |
Dr. David Thomas Boyd, M.D., M.B.A. Radiology Medicare: Accepting Medicare Assignments Practice Location: 19500 Sandridge Way, Suite 420, Leesburg, VA 20176 Phone: 571-375-8601 Fax: 571-223-6773 | |
Dr. Daniel Alexander Chu, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 19500 Sandridge Way, Suite 420, Leesburg, VA 20176 Phone: 571-375-8601 Fax: 571-223-6773 | |
Arun Kumar, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 19500 Sandridge Way, Suite 420, Leesburg, VA 20176 Phone: 571-375-8601 Fax: 571-223-6773 |